This online series of workshops will arm you with the information you need to overcome challenges and achieve compliance with EU MDR.
The hot issues are related to compliance, EU MDR and recalls.
For too long this industry has lagged the pharma sector in terms of using data analytics to predict market trends. It’s time to change that.
The first critical step in being able to feel confident about your clinical evaluation reports (CERs) is to ensure you know exactly what they entail.
The agency will be improving postmarket surveillance, looking at issues that come up once a device is on the market, and promoting innovation.
Take a proactive approach to achieving regulatory compliance.
A review of how to incorporate complaint handling and risk management into the postmarket surveillance process.
A review of the important aspects of risk management and post-market surveillance processes, and how to resolve common concerns.